01 7Imfinzi
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 2,042
2019 Revenue in Millions : 1,469
Growth (%) : 39
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 2,412
2020 Revenue in Millions : 2,042
Growth (%) : 18
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 2,784
2021 Revenue in Millions : 2,412
Growth (%) : 15
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 4,237
2022 Revenue in Millions : 2,784
Growth (%) : 52
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 19
2016 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 633
2017 Revenue in Millions : 19
Growth (%) : 3232%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 1,469
2018 Revenue in Millions : 633
Growth (%) : 132
LOOKING FOR A SUPPLIER?
